Arturo Molina

Arturo Molina, M.D., M.S., FACP, has been chief medical officer at Sutro BioPharma since February 2016. From February 2013 to February 2016, Dr. Molina served as vice president of oncology scientific innovation at Johnson & Johnson’s California Innovation Center, an organization focused on building early-stage collaborations with emerging companies. Previously, Dr. Molina served as chief medical officer and vice president of clinical development for Johnson and Johnson’s Ortho Biotech Oncology Research and Development, a unit of Cougar Biotechnology, Inc., chief medical officer of Cougar Biotechnology, Inc., senior director and interim head of oncology/hematology in the Department of Medical Research and Clinical Development at Biogen Idec, Inc., and senior director of medical affairs at IDEC Pharmaceuticals Corporation. Since 2006, Dr. Molina has served as a National Advisory committee member for the Harold Amos Medical Faculty Development Program of the Robert Wood Johnson Foundation. From 1991 to 2002, Dr. Molina was a faculty staff physician in the Department of Hematology/Bone Marrow Transplantation and Department of Medical Oncology/Therapeutics Research at City of Hope Comprehensive Cancer Center and adjunct professor from 2004 to 2007. Dr. Molina was also on the board of directors of the City of Hope Medical Group. Dr. Molina received a B.S. in zoology and B.A. in psychology from the University of Texas at Austin and an M.S. in physiology and M.D. from Stanford University School of Medicine. He is board certified in internal medicine and medical oncology, has an active California medical license and is a staff physician (volunteer) in the oncology clinic at the Veterans Affairs Palo Alto Health Care System. Dr. Molina has been an adjunct clinical associate professor (volunteer) in the Department of Medicine, Division of Oncology, Stanford University School of Medicine, since 2019.